what does aarti drugs do

Aarti Drugs Limited is engaged in the manufacturing and selling of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, and Formulations, and exports these products to over 100 countries globally.

what products does aarti drugs make

The company produces products such as Aceclofenac API, Diphenyl Sulphone, Sodium Benzoate Sulfinate, Antiprotozoal Drugs, and various other Pharma Ingredients and Raw Materials.

what sector is aarti drugs in

Aarti Drugs Limited operates in the pharmaceutical sector, specifically focusing on the production of APIs, intermediates, and related chemicals for the pharmaceutical industry.

when was aarti drugs founded

Aarti Drugs Limited was established in the year 1984 as part of the Aarti Group of Industries.

Aarti Drugs Limited is a part of the Aarti Group of Industries, which is a $1000 million group.

Aarti Drugs Limited (AARTIDRUGS) Share Price Today — ₹397.05

Aarti Drugs Limited (AARTIDRUGS) live stock price is ₹397.05 with a change of -0.85% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Aarti Drugs Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Aarti Drugs Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

AARTIDRUGS

NSEBSE

Aarti Drugs Limited

Healthcare· Pharmaceuticals & Biotechnology· INE767A01016· Scrip: 524348

EN हिन्दी ગુજરાતી मराठी

₹397.05

▼ 3.40 (-0.85%)

7/5/2026, 3:28:15 pm

NSE

₹397.05

▼ 3.40

-0.85%

BSE

₹375.05

▲ 1.30

+0.00%

245 trading days · 1Y period

TODAY 

Open400.45

High402.00

Low392.40

Prev Close400.45

Volume1.09L

Value₹4.3Cr

L: 392.40H: 402.00

52 WEEK

Low₹318.95

High₹564.05

32% of 52W range

Info

Face Value₹10

Listed2003-09-19

ISININE767A01016

SeriesB

BSE Scrip524348

Key Metrics

1D

+0.63%

1W

+1.01%

1M

+12.00%

3M

+0.17%

6M

-27.42%

Valuation

P/E (TTM)23.53

P/E (Qtr Ann.)23.13

P/Sales1.37

Mkt Cap₹3108 Cr

Growth (QoQ)

Revenue-6.97%

PAT+6.09%

EPS+6.01%

Profitability

EBITDA Margin11.6%

Net Margin6.7%

TTM EBITDA M.11.0%

TTM Net M.6.5%

Dividend

Yield0.53%

Latest DPS₹2

Payout Ratio49.3%

Growth+100.00%

TTM Revenue

₹2268 Cr

TTM EBITDA

₹249 Cr

TTM PAT

₹146 Cr

TTM EPS

₹15.97

Rev/Share

₹248.5

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	557 Cr	518 Cr	65 Cr	51 Cr	37 Cr	₹4.06
2024-09-30	598 Cr	554 Cr	60 Cr	46 Cr	35 Cr	₹3.83
2024-06-30	493 Cr	458 Cr	47 Cr	35 Cr	27 Cr	₹2.93
2024-03-31	620 Cr	557 Cr	78 Cr	64 Cr	47 Cr	₹5.15
2023-12-31	606 Cr	556 Cr	64 Cr	52 Cr	37 Cr	₹3.99
2023-09-30	642 Cr	586 Cr	69 Cr	56 Cr	40 Cr	₹4.29
2023-03-31	742 Cr	670 Cr	86 Cr	73 Cr	56 Cr	₹6.07
2022-12-31	664 Cr	615 Cr	62 Cr	50 Cr	37 Cr	₹3.96

Shareholding Pattern

CURRENT — 2026-03-31

Promoter55.0%

FII1.6%

DII10.2%

Public45.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2026-02-09	Dividend	Interim Dividend - Rs 2 Per Share
2025-02-04	Dividend	Interim Dividend - Re 1 Per Share
2024-09-05	Other	Buy Back
2024-02-06	Dividend	Interim Dividend - Re 1 Per Share
2023-08-04	Other	Buy Back
2023-02-08	Dividend	Interim Dividend - Rs 1 Per Share
2022-02-09	Dividend	Interim Dividend - Re 1 Per Share
2021-03-30	Buyback	Buyback
2020-11-03	Dividend	Interim Dividend - Rs 2.5 Per Share
2020-09-30	Bonus	Bonus 3:1
2020-02-17	Dividend	Interim Dividend - Rs 2 Per Share
2019-07-26	Dividend	Annual General Meeting/Dividend - Re 1 Per Share
2019-03-28	Buyback	Buyback
2018-08-01	Dividend	Annual General Meeting/Dividend- Re 1 Per Share
2018-01-18	Buyback	Buyback
2017-08-09	Dividend	Annual General Meeting/Dividend - Re 1/- Per Share
2016-11-01	Other	Buy Back
2016-07-13	Other	Annual General Meeting
2016-03-22	Dividend	Interim Dividend - Rs 3/- Per Share (Purpose Revised)
2016-02-12	Dividend	Interim Dividend - Rs 1.50/- Per Share (Purpose Revised)

Earnings Transcripts

Aarti Drugs Limited has informed the Exchange about Investor Presentation

7 Nov 2025NSE39K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

19 Jul 2025NSE36K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

6 May 2025NSE47K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

29 Jan 2025NSE45K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

24 Jan 2024NSE39K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

19 Oct 2023NSE42K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

26 Sept 2023NSE12K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

21 Jul 2023NSE39K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

2 May 2023NSE42K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

27 Jan 2023NSE40K chars

Read →

Aarti Drugs Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Me...

31 Oct 2022NSE50K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

20 Oct 2022NSE42K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

4 Aug 2022NSE13K chars

Read →

Aarti Drugs Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Me...

3 Aug 2022NSE50K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

27 Jul 2022NSE42K chars

Read →

Aarti Drugs Limited has informed the Exchange about revised Q4FY22 Results Presentation

7 Jun 2022NSE45K chars

Read →

Aarti Drugs Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Me...

16 May 2022NSE40K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

9 May 2022NSE45K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

31 Jan 2022NSE43K chars

Read →

Aarti Drugs Limited has informed the Exchange about Investor Presentation

27 Oct 2021NSE45K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-04-30	372.70	378.80	370.00	376.30	89,293
2026-04-29	381.70	384.60	371.00	373.35	94,778
2026-04-28	380.80	384.70	375.90	379.45	1.20L
2026-04-27	369.60	385.30	366.70	381.80	2.26L
2026-04-24	371.05	374.20	363.25	366.70	1.12L
2026-04-23	368.95	379.00	367.25	371.95	2.52L
2026-04-22	364.00	368.95	360.85	366.95	1.15L
2026-04-21	365.20	368.30	361.25	361.60	85,037
2026-04-20	375.00	375.45	362.60	365.20	2.14L
2026-04-17	366.00	376.90	366.00	373.20	1.17L
2026-04-16	367.70	374.00	363.30	368.40	1.52L
2026-04-15	359.30	367.50	356.50	365.30	1.33L
2026-04-13	350.25	356.35	343.50	352.90	1.36L
2026-04-10	359.95	363.00	353.00	355.10	2.41L
2026-04-09	364.75	367.85	356.15	357.65	88,052
2026-04-08	369.00	369.00	355.90	361.55	1.60L
2026-04-07	355.00	362.90	350.00	356.90	84,986
2026-04-02	340.00	354.60	335.55	352.70	1.05L
2026-04-01	330.00	348.65	322.05	346.40	1.74L
2026-03-27	345.00	345.85	328.85	330.70	2.06L
2026-03-25	338.80	348.00	335.70	341.10	1.19L
2026-03-24	333.00	339.20	327.95	335.45	1.11L
2026-03-20	340.00	348.00	338.30	343.15	1.01L
2026-03-19	336.00	357.00	334.10	337.60	2.98L
2026-03-18	336.00	349.90	332.85	341.15	1.28L
2026-03-17	337.10	344.50	332.90	334.15	1.32L
2026-03-16	349.00	349.00	335.50	339.10	1.44L
2026-03-13	355.00	358.05	346.10	347.75	92,297
2026-03-12	353.15	358.75	345.00	356.45	85,129
2026-03-11	353.45	362.45	349.75	352.75	1.55L

Frequently Asked Questions

About

Aarti Drugs Limited is an Indian pharmaceutical company primarily focused on manufacturing and marketing a range of generic and specialty medicines. Key products include cardiovascular, central nervous system, and anti-infective drugs. Notably, the company was founded in 1993 and has established itself as a significant player in the generic drug sector.

Advertisement

BOARD OF DIRECTORS

Bhaskar Narayan Thorat Disclosure Requirement

Managing Director

Bhaskar Narayan Thorat

Independent Director

Rushikesh Deole